
Hummingbird Bioscience
@hummingbirdbio
Hummingbird Bioscience is a clinical stage biotech company focused on discovering and developing antibody-based biotherapeutics for the treatment of cancer.
ID: 3369056830
http://www.hummingbirdbioscience.com 10-07-2015 10:10:34
212 Tweet
207 Followers
155 Following

Ben Ayers, VP of Antibody-Drug Conjugates at Hummingbird Bioscience, will be presenting our novel dual-payload technologies at Antibody Engineering & Therapeutics Asia. Antibody Engineering #adc #drugresistance #biotech





Jerome Boyd-Kirkup, Chief Scientific Officer at Hummingbird Bioscience, will be presenting our novel dual-payload technologies at Antibody Engineering & Therapeutics San Diego. Read more in the interview: bit.ly/41lJYqF Antibody Engineering #adc #drugresistance #biotech


Press release: bit.ly/3PqPdyc Hummingbird Bioscience has granted Immunome, Inc. an exclusive, worldwide license to novel monoclonal antibodies that are directed to a single undisclosed target. #biotech #licensing #outlicensing #ADC


Hummingbird Bioscience will be sharing Trial-in-Progress posters for HMBD-001 trials NCT05919537 and NCT05910827 at #AustralianPrecisionOncologySymposium2025 #APOS25 #PrecisionOncology Omico Australia


Our Chief Executive Officer Piers Ingram is attending BioCentury East-West #Biopharma Summit to discuss the upcoming innovations in Asia’s biopharma landscape. We look forward to meeting the community and catching up! Asia CEO Roundtable 5 March 2025 11:15AM-12:30PM SGT

